"The Oracle Clinical One platform is a game-changer," said Michele Taylor-Scott, head of data management at Health Decisions. "We have used Clinical One for stand-alone randomization and trial supply management and are excited to now be able to use it for data collection. Clinical One is very user-friendly and we feel it will enable us to reduce not only database build timelines, but also database lock timelines, which are both critical in clinical trials. I say that with confidence because with Clinical One, we have the ability to build a full study in a matter of weeks, instead of months, and mid-study changes or post-production changes can be done in real-time without a lengthy migration process."
Current eClinical technology has not kept pace with the acceleration of science and clinical research which drives up trial costs. According to Gartner's 2020 Industry Vision report, "the current rate of trial cost increase is unsustainable, and clinical leaders must challenge the existing model and enable new approaches to take hold." (1)
Oracle Clinical One Data Collection collects data from any source - forms, wearable sensors, patient apps, electronic health records (EHR), labs - and harmonizes it in a single place. This expanded data gives sites and study teams a more complete picture of the patient’s experience, and ultimately, the safety and efficacy of the investigative therapy, allowing them to make better decisions. And, because Clinical One is a unified platform, sites can randomize, dispense drug, and collect patient data in one system.
"Using Oracle Clinical One will have a positive impact on our data collection and randomization processes for current and future clinical trials as we help bring new women’s health therapies to market," added Taylor-Scott.
Because it is easily configurable, Clinical One Data Collection meets the needs of all trial types - from the simplest Phase I and Post-Market studies to the most complex Phase III studies, across all therapeutic areas. For example, Clinical One is already being used across the industry for many trials including those focused on COVID-19 treatments and vaccines.
"The industry has been asking for technology that supports a new way to approach clinical trials that is simpler, easier, and lower cost, but also accommodates the evolving needs of decentralized trials. To meet this need, we, as an industry, must think and act differently," said Steve Rosenberg, senior vice president and general manager, Oracle Health Sciences. "Our goal is to deliver on this promise by providing the industry with a unified platform that supports today's needs as well as tomorrow's requirements. Clinical One Data Collection supports event-based data collection and streamlines workflow, providing our customers with the agility and cost-savings they need to get therapies to market faster."
Recently, Oracle also announced its Clinical One Randomization and Supplies Management Cloud Service, which reduces the time required for study set up from nearly two months to just a few days. For more information about Clinical One, please visit:
About Oracle Health SciencesAs a leader in Life Sciences cloud technology, Oracle Health Sciences' Clinical One and Safety One are trusted globally by professionals in both large and emerging companies engaged in clinical research and pharmacovigilance. With over 20 years' experience, Oracle Health Sciences is committed to supporting clinical development, delivering innovation to accelerate advancements, and empowering the Life Sciences industry to improve patient outcomes. Oracle Health Sciences. For life.
About OracleThe Oracle Cloud offers a complete suite of integrated applications for Sales, Service, Marketing, Human Resources, Finance, Supply Chain and Manufacturing, plus Highly Automated and Secure Generation 2 Infrastructure featuring the Oracle Autonomous Database.
1 Gartner, Industry Vision: Life Science CIOs Must Transform Clinical Development With Digital Trials Refreshed 15 January 2020, Published 21 August 2018